SCHEMBL20124941

SCHEMBL20124941

NC1C(OCc2ccccc2)OC(CO)C(OCc2ccccc2)C1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.48
TACR2 P21452 1/20 0.43
SSTR5 P35346 2/20 0.43
SSTR1 P30872 1/20 0.43
SSTR2 P30874 1/20 0.43
SSTR4 P31391 1/20 0.43
SSTR3 P32745 1/20 0.43
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
GJB2 P29033 2/20 0.41
PDE4D Q08499 1/20 0.41
PTPN1 P18031 2/20 0.40
CDC25B P30305 2/20 0.40
PDPK1 O15530 1/20 0.40
MTOR P42345 1/20 0.40
FGF1 P05230 1/20 0.40
FGF2 P09038 1/20 0.40
VEGFA P15692 1/20 0.40
HPSE Q9Y251 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2306913 0.90 SLC6A2 (0.44) SLC6A2TACR2SSTR5SSTR1SSTR2
SCHEMBL2310381 0.89 SLC6A2 (0.58) SLC6A2SSTR5GJB2PDE4D
SCHEMBL2310373 0.89 SLC6A2 (0.58) SLC6A2SSTR5GJB2PDE4D
SCHEMBL2795858 0.89 SLC6A2 (0.45) SLC6A2TACR2SSTR5SSTR1SSTR2
SCHEMBL2795854 0.89 SLC6A2 (0.45) SLC6A2TACR2SSTR5SSTR1SSTR2
SCHEMBL10352261 0.88 SLC6A2 (0.52) SLC6A2TACR2SSTR5SSTR1SSTR2
SCHEMBL23758909 0.87 SLC6A2 (0.51) SLC6A2TACR2SSTR5SSTR1SSTR2
SCHEMBL7151103 0.87 SLC6A2 (0.51) SLC6A2TACR2SSTR5SSTR1SSTR2
SCHEMBL2323060 0.87 SLC6A2 (0.51) SLC6A2TACR2SSTR5SSTR1SSTR2
SCHEMBL1039870 0.87 SLC6A2 (0.51) SLC6A2TACR2SSTR5SSTR1SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2703495-B1 METHOD FOR DETECTING CANCER CELL USING FLUORESCENTLY LABELED L-GLUCOSE DERIVATIVE, AND CANCER CELL-IMAGING AGENT COMPRISING FLUORESCENTLY LABELED L-GLUCOSE DERIVATIVE UNIV HIROSAKI (JP) 2018-05-09 EP disclosed